Release Date: 12/09/17 17:44 Summary: Appendix 3Y Steve Gostlow - 11 September 2017 Price Sensitive: No Download Document 260.27KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status